Tranexamic acid reduces blood loss and transfusion in single-stage bilateral combined surgery for developmental dysplasia of the hip: A retrospective study
Journal of Children's Orthopaedics · 2026-06 · 20 (3) · 241-246
DOI: 10.1177/18632521261429003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Children's Orthopaedics, online erschienen am 20.03.2026. Verfasst von Shiwei Li und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Surgery, West China Hospital, Sichuan University, Chengdu, China. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Clinical Research Incubation Project of West China Hospital of Sichuan University.
Abstract (Originalsprache)
Objective
To determine whether tranexamic acid (TXA) reduces blood loss and transfusion rate in single-stage bilateral combined surgery for developmental dysplasia of the hip (DDH) in children.
Methods
A retrospective study was conducted on 148 children with bilateral DDH who underwent single-stage bilateral combined surgery between March 2021 and May 2025. Patients were categorized into a TXA group ( n = 71) and a control group ( n = 77) based on TXA administration. The TXA group received a single intravenous bolus of TXA 15 mg/kg preoperatively, while the control group received no intervention. Complete blood count tests were obtained preoperatively and at 24 h postoperatively. Estimated blood loss (EBL), transfusion rate, operative duration, and complications were compared.
Results
The TXA group exhibited significantly lower EBL compared with the control group (117.5 ± 7.7 mL vs. 171.4 ± 11.3 mL; p < 0.001). The total transfusion rate was also lower in the TXA group (5.6 % vs. 16.9 %; p = 0.03), as well as the intraoperative transfusion rate (1.4% vs. 11.7%; p = 0.03). The median surgical duration was 2.3 h in both groups, with no significant difference ( p = 0.29). One postoperative infection occurred in each group (1.4 % vs. 1.3 %; p = 1), and no cases of seizures or deep vein thrombosis were observed.
Conclusions
TXA significantly reduces EBL and both total and intraoperative transfusion rates in children undergoing single-stage bilateral combined surgery for DDH, without affecting the risk of complications.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatric Surgery, West China Hospital, Sichuan University, Chengdu, China.
ORCID-Profile: Shiwei Li, Xueyang Tang, Xiaodong Yang
Förderung
- Clinical Research Incubation Project of West China Hospital of Sichuan University
Zitieren
APA
Li, S., Tang, X., & Yang, X. (2026). Tranexamic acid reduces blood loss and transfusion in single-stage bilateral combined surgery for developmental dysplasia of the hip: A retrospective study. Journal of Children's Orthopaedics, 20(3), 241-246. https://doi.org/10.1177/18632521261429003
Vancouver
Li S, Tang X, Yang X. Tranexamic acid reduces blood loss and transfusion in single-stage bilateral combined surgery for developmental dysplasia of the hip: A retrospective study. Journal of Children's Orthopaedics. 2026;20(3):241-246. doi:10.1177/18632521261429003
BibTeX
@article{Li2026,
author = {Li, Shiwei and Tang, Xueyang and Yang, Xiaodong},
title = {Tranexamic acid reduces blood loss and transfusion in single-stage bilateral combined surgery for developmental dysplasia of the hip: A retrospective study},
journal = {Journal of Children's Orthopaedics},
year = {2026},
volume = {20},
number = {3},
pages = {241--246},
doi = {10.1177/18632521261429003}
}
EUVIMED